Racial and socioeconomic inequities in breast cancer screening before and during the COVID-19 pandemic: analysis of two cohorts of women 50 years +

被引:17
作者
Monsivais, Pablo [1 ]
Amiri, Solmaz [2 ]
Robison, Jeanne [3 ,4 ]
Pflugeisen, Chaya [3 ]
Kordas, Gordon [5 ]
Amram, Ofer [1 ,6 ]
机构
[1] Washington State Univ, Elson S Floyd Coll Med, Dept Nutr & Exercise Physiol, 412 E Spokane Falls Blvd, Spokane, WA 99202 USA
[2] Washington State Univ, Elson S Floyd Coll Med, Inst Res & Educ Adv Community Hlth, Seattle, WA USA
[3] MultiCare Inst Res & Innovat, Tacoma, WA USA
[4] MultiCare Deaconess Canc & Blood Specialty Ctr, Spokane, WA 99204 USA
[5] Washington State Univ, Elson S Floyd Coll Med, Dept Med Educ & Clin Sci, Spokane, WA USA
[6] Washington State Univ, Paul G Allen Sch Global Anim Hlth, Pullman, WA 99164 USA
关键词
Cancer prevention; Screening mammography; Race and ethnicity; Socioeconomic status; Health equity; Covid-19; pandemic; Health services;
D O I
10.1007/s12282-022-01352-2
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Background Routine screening mammography at two-year intervals is widely recommended for the prevention and early detection of breast cancer for women who are 50 years + . Racial and other sociodemographic inequities in routine cancer screening are well-documented, but less is known about how these long-standing inequities were impacted by the disruption in health services during the COVID-19 pandemic. Early in the pandemic, cancer screening and other prevention services were suspended or delayed, and these disruptions may have had to disproportionate impact on some sociodemographic groups. We tested the hypothesis that inequities in screening mammography widened during the pandemic. Methods A secondary analysis of patient data from a large state-wide, non-profit healthcare system in Washington State. Analyses were based on two mutually exclusive cohorts of women 50 years or older. The first cohort (n = 18,197) were those women screened in 2017 who would have been due for repeat screening in 2019 (prior to the pandemic's onset). The second cohort (n = 16,391) were women screened in 2018 due in 2020. Explanatory variables were obtained from patient records and included race/ethnicity, age, rural or urban residence, and insurance type. Multivariable logistic regression models estimated odds of two-year screening for each cohort separately. Combining both cohorts, interaction models were used to test for differences in inequities before and during the pandemic. Results Significant sociodemographic differences in screening were confirmed during the pandemic, but these were similar to those that existed prior. Based on interaction models, women using Medicaid insurance and of Asian race experienced significantly steeper declines in screening than privately insured and white women (Odds ratios [95% CI] of 0.74 [0.58-0.95] and 0.76 [0.59-0.97] for Medicaid and Asian race, respectively). All other sociodemographic inequities in screening during 2020 were not significantly different from those in 2019. Conclusions Our findings confirm inequities for screening mammograms during the first year of the COVID-19 pandemic and provide evidence that these largely reflect the inequities in screening that were present before the pandemic. Policies and interventions to tackle long-standing inequities in use of preventive services may help ensure continuity of care for all, but especially for racial and ethnic minorities and the socioeconomically disadvantaged.
引用
收藏
页码:740 / 746
页数:7
相关论文
共 21 条
[1]  
Amram O., 2020, DEV VULNERABILITY IN
[2]   Covid-19 - Implications for the Health Care System (vol 383, pg 1483, 2020) [J].
Blumenthal, D. .
NEW ENGLAND JOURNAL OF MEDICINE, 2020, 383 (17) :1698-1698
[3]   Recommendations on screening for colorectal cancer in primary care [J].
不详 .
CANADIAN MEDICAL ASSOCIATION JOURNAL, 2016, 188 (05) :340-348
[4]   COVID-19 impact on screening test volume through the National Breast and Cervical Cancer early detection program, January-June 2020, in the United States [J].
DeGroff, A. ;
Miller, J. ;
Sharma, K. ;
Sun, J. ;
Helsel, W. ;
Kammerer, W. ;
Rockwell, T. ;
Sheu, A. ;
Melillo, S. ;
Uhd, J. ;
Kenney, K. ;
Wong, F. ;
Saraiya, M. ;
Richardson, L. C. .
PREVENTIVE MEDICINE, 2021, 151 :106559
[5]  
Freeman Harold P, 2005, Surg Oncol Clin N Am, V14, P655, DOI 10.1016/j.soc.2005.06.002
[6]  
Harris DM, 2003, J NATL MED ASSOC, V95, P693
[7]   Prevention and control of non-communicable diseases in the COVID-19 response [J].
Kluge, Hans Henri P. ;
Wickramasinghe, Kremlin ;
Rippin, Holly L. ;
Mendes, Romeu ;
Peters, David H. ;
Kontsevaya, Anna ;
Breda, Joao .
LANCET, 2020, 395 (10238) :1678-1680
[8]   The Impact of the COVID-19 Pandemic on Immunization Campaigns and Programs: A Systematic Review [J].
Lassi, Zohra S. ;
Naseem, Rabia ;
Salam, Rehana A. ;
Siddiqui, Faareha ;
Das, Jai K. .
INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH, 2021, 18 (03) :1-19
[9]   Effects of the COVID-19 Pandemic on Cancer-Related Patient Encounters [J].
London, Jack W. ;
Fazio-Eynullayeva, Elnara ;
Palchuk, Matvey B. ;
Sankey, Peter ;
McNair, Christopher .
JCO CLINICAL CANCER INFORMATICS, 2020, 4 :657-665
[10]  
Miller MJ, 2021, MMWR-MORBID MORTAL W, V70, P109, DOI [10.15585/mmwr.mm7004a1, 10.15585/mmwr.mm7004a1externalicon]